A Prospective, Open label, Randomized, Comparative, Multicentric trial to evaluate the Efficacy and Safety of Desvenlafaxine succinate ER tablet in the Management of Major Depressive Disorder.
Phase of Trial: Phase III
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Desvenlafaxine (Primary) ; Venlafaxine
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Emcure Pharmaceuticals
- 03 Feb 2010 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 30 Jun 2009 New trial record